Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Discovery of potent and selective mu-opiate receptor agonists

April 28, 1997

Mimetix initiates clinical trial with injectable form of naproxen

April 25, 1997

CoCensys discovers potent, water-soluble allosteric modulators of GABA-A receptor

April 25, 1997

Neurotrophic/neuroprotective agents described by Synthelabo

April 25, 1997

Clinical results from international comparative study of olanzapine and haloperidol

April 24, 1997

Eletriptan enters phase III trials

April 24, 1997

Yamasa describes cognition-enhancing agents

April 24, 1997

Arzneimittelwerk describes new anticonvulsants

April 24, 1997

Grape seed proanthocyanidins compared to other antioxidants in vitro and in vivo

April 24, 1997

Canadian clearance for Naropin

April 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...